Rifampicin May Be Safest Treatment Option For Latent TB Infection In Patients Without Contraindication, Study Shows
February 11, 2020
Infectious Disease Advisor (2/10, Masoud) reports that “in patients without a contraindication, rifampicin may be the safest treatment option for latent tuberculosis (TB) infection, according to” study results published in the Lancet Infectious Diseases....